| Wall Street Journal. Europe 2001 Susannah Rodgers |
| Title | Subject | Authors |
|---|
| Acambis lands contract with U.S. government.(vaccine contract) | Business, international | Susannah Rodgers |
| Alliance Unichem posts results below expectations.(2001 first-half) | Business, international | Susannah Rodgers |
| AstraZeneca beats market expectations for pretax profit. | Business, international | Susannah Rodgers |
| AstraZeneca says it expects to meet annual forecast. | Business, international | Susannah Rodgers |
| Biocompatibles posts wider loss.(Stent delay cited; stronger 2nd half forecast.) | Business, international | Susannah Rodgers |
| Bioglan's shares plunge on wider 1st-half loss. | Business, international | Susannah Rodgers |
| Bioglan's wrangling may be tied to deal.(news of skin-care pact to be announced Friday)(Abstract) | Business, international | Susannah Rodgers |
| Celltech's earnings beat forecasts; firm makes German acquisition. | Business, international | Susannah Rodgers |
| Galen's profit rose 75% in quarter on U.S. sales.(2001 third-quarter) | Business, international | Susannah Rodgers |
| Oxford loss widened in half.(Oxford GlycoSciences's 2001 first-half) | Business, international | Susannah Rodgers |
| Regulatory delays shortfall in capacity stall new drugs.(Biotech companies forced to tap equity markets.) | Business, international | Susannah Rodgers |
| Shire's earnings rise 66%, topping estimates.(2001 second-quarter) | Business, international | Susannah Rodgers |
| SkyePharma's loss widened in first half.(2001) | Business, international | Susannah Rodgers |
| U.K. drug companies expect strong results for 3rd quarter.(GlaxoSmithKline PLC and AstraZeneca PLC) | Business, international | Susannah Rodgers |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
